Sources | Names Used |
---|---|
CTRPv2 | carboplatin:etoposide (40:17 mol/mol) |
PharmacoGx | carboplatin:etoposide (40:17 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LTBR | CTRPv2 | pan-cancer | AAC | -0.22 | 2e-09 |
mRNA | CD63 | CTRPv2 | pan-cancer | AAC | -0.22 | 9e-10 |
mRNA | SERINC3 | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-11 |
mRNA | RTFDC1 | CTRPv2 | pan-cancer | AAC | -0.2 | 6e-11 |
mRNA | TPD52L2 | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-10 |
mRNA | VAMP3 | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-08 |
mRNA | ANXA5 | CTRPv2 | pan-cancer | AAC | -0.2 | 6e-07 |
mRNA | RNF181 | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-11 |
mRNA | CD151 | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-08 |
mRNA | ATP6V0E1 | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-09 |